Plants can be models for the synthesis of a large number of drugs and in the case of phytoteractic plants are directly part of their composition. The 2006 National Policy of Medicine and Phytoteractic Plants (PNPMF) is considered to be the regulatory milestone for Brazilian plant therapy. The Brazilian government has developed actions to implement it, but its progress has been limited by factors such as insufficient knowledge of health professionals about phytotherapy. Exploratory and descriptive research has highlighted the impact of the PNPMF on health graduation in a state of Brazil’s north-east. The rationale was based on literature review on higher education in health in Brazil, national curriculum guidelines, PNPMF, medicinal plants in public health and views of key groups in the area. A quality-quantitative approach has been used using triangulation between methods.